M2 PRESSWIRE-March 8, 2011-ShamrockStocks.com: Lucky Picks of The Day: (OTCBB:TBIO) - (OTCBB:NIVM)- (OTCBB:SHMX)(C)1994-2011 M2 COMMUNICATIONS
RDATE:08032011
Rochester NY -- www.shamrockstocks.com names (OTCBB:TBIO) Transgenomic, Inc., (OTCBB:NIVM) National Investment Managers, Inc., and (OTCBB:SHMX) Shamika2Gold, Inc. it's "Lucky Picks of the Day!
To feature your publicly traded company in our alers email us at info@shamrockstocks.com.
Also, you can receive up to the minute stock alerts via our Twitter page www.twitter.com/shamrockstocks
Visit http://www.shamrockstocks.com/disclaimer.html for current profiles
Visit: www.shamrockstocks.com
About Transgenomic, Inc.
Transgenomic, Inc. (www.transgenomic.com ) is a global biotechnology company specializing in high sensitivity genetic variation and mutation analysis, providing products and services in DNA mutation detection and discovery for clinical research, clinical molecular diagnostics and pharmacogenomics analyses. Product offerings include the WAVE(R) Systems and associated consumables specifically designed for use in genetic variation detection and single- and double-strand DNA/RNA analysis and purification. With broad applicability to genetic research, nearly 1,500 systems have been shipped to customers in more than 50 countries. The SURVEYOR(R) Mutation Detection Kits provide reagents and protocols for high sensitivity detection of mutations in DNA. HANABI automated chromosome harvesting systems improve laboratory productivity with consistent quality compared with manual methods for cytogenetic karyotyping and FISH analyses. Service offerings include the Transgenomic Molecular Laboratory, which provides reference laboratory services specializing in molecular diagnostics including Mitochondrial Disorders, Oncology and Hematology, Molecular Pathology and Inherited Diseases. Transgenomic Pharmacogenomics Services is a CRO for pharmacogenomic, translational research and clinical trials. In December of 2010, we acquired another CLIA certified laboratory in New Haven, Connecticut which specializes in genetic disorders associated with cardiomyopathies and channelopathies. We believe there is a significant opportunity for us to continue growing the demand for molecular-based testing by leveraging our technologies, experience and expertise in biomarker analysis. In addition, we continue to seek out and evaluate new technologies and new laboratory tests which will further extend our offerings in our Molecular Diagnostics Laboratory and our Pharmacogenomics Services Lab.
News Today:
OMAHA, Neb., March 8, 2011-- Transgenomic, Inc. (OTC Bulletin Board: TBIO) today announced the following Webcast:
What: Transgenomic, Inc. Fourth Quarter 2010 Financial Results and Business Update Conference Call
When: Friday, March 11, 2011 @ 11:00 a.m. Eastern
Where: http://www.transgenomic.com/events.asp?id=6
How: Live over the Internet -- Simply log on to the web at the address above.
Contact: Investor Relations, 402-452-5400
To access the call via telephone, call 800-895-1715 from the U.S. or Canada or 785-424-1059 for international participants and enter conference ID TRANS. A telephone replay will be available from 1:00 p.m. Eastern Time March 11, 2011 through 11:59 p.m. Eastern Time on March 25, 2011 by dialing 800-723-0528 (domestic) or 402-220-2654 (international).
Visit: www.shamrockstocks.com
About National Investment Managers, Inc.
National Investment Managers Inc. is a holding company and a consolidator of pension plan administration, investment management and insurance businesses. Its strategy includes a custom-tailored acquisition formula for each acquired business, which allows local and regional entities to retain their autonomy while benefiting from the reach that a national presence offers. In addition, the Company's approach offers entrepreneurs in these businesses an exit strategy suited to their specific needs. National Investment Managers targets businesses with stable cash flows and high operating margins to ensure successful integration of operations once a sale is concluded. Acquired companies continue to operate under their own brands, usually with minimal staff turnover to ensure that relationships of many years' standing are not disrupted. At the same time, these formerly small businesses can cross-sell related financial services under the National Investment Managers umbrella and enjoy administrative and other support from around the country.
The member firms of National Investment Managers provide pension administration services, retirement planning, defined benefit services, asset preservation, general insurance and asset management services. Wholly-owned subsidiaries of National Investment Managers are based in Anchorage, AK; Laguna Hills, CA; Marina Del Rey, CA; Denver, CO; Southington, CT; Lake Mary, FL; Pikesville, MD; North Attleboro, MA; Haddonfield, NJ; New York City, NY; Yorktown Heights, NY; Beaverton, OR; Harrisburg, PA; Horsham, PA; Wayne, PA; Warwick, RI; Houston, TX; and Seattle, WA. NIVM's corporate headquarters are located in Dublin, OH.
News Today:
DUBLIN, OH, Mar 08, 2011-- National Investment Managers (OTCBB: NIVM), a nationally-based and regionally-operated retirement plan administration and investment management company, with over $11 billion of assets under administration, today announced that it has entered into a definitive agreement for the sale of the Company to an entity owned and controlled by Stonehenge Opportunity Fund III, LP, an entity managed by Stonehenge Partners, Inc., for $42.5 million in cash, subject to working capital adjustments. Stonehenge Partners, Inc., based in Columbus, Ohio, manages more than $700 million of private capital and focuses on investing in middle-market businesses.
Completion of the sale is subject to certain terms and conditions, including shareholder approval. A special meeting of shareholders will be held on Friday, March 18, 2011 to vote on the transaction. The Company is mailing a notice of meeting and proxy statement to shareholders of record. The record date for determining shareholders entitled to vote is February 23, 2011.
As previously reported, the Company has received voting agreements from holders of its Preferred and Common Stock sufficient to assure all required shareholder approvals of the sale to Stonehenge.
The Company expects that, after payment of NIVM's outstanding debt and other liabilities, $8 million of the purchase price proceeds will be available for distribution to shareholders. The anticipated distributions are as follows:
-- Series A Preferred Stock--$0.50 per share
-- Series B Preferred Stock--$0.43 per share
-- Series C Preferred Stock--$2.41 per share
-- Series D Preferred Stock--$3.95 per share
-- Series E Preferred Stock--$38.55 per share
-- Common Stock--$0.02 per share
Further information regarding the definitive agreement, the proposed sale and the special meeting of shareholders is contained in a Current Report on Form 8-K that the Company filed today with the Securities and Exchange Commission.
The investment banking group of Carl Marks Advisory Group, LLC is acting as financial advisor to the Company.
Visit: www.shamrockstocks.com
About Shamika2Gold, Inc.
Shamika2Gold is an international junior gold company with strategic holdings in countries with potential high value targets that have been overlooked by the mining industry. The company's strategy is to become a global exploration and production company. Shamika2Gold, Inc. is 51% owned by Shamika Resources, Inc., a private company domiciled in Canada. The corporate strategy is to develop a portfolio of mineral companies, unlocking value for shareholders, and opening up multinational access to the capital markets.
Cautionary Note to U.S. Investors -- The United States Securities and Exchange Commission permits U.S. mining companies, in their filings with the SEC, to disclose only those mineral deposits that a company can economically and legally extract or produce. U.S. Investors are urged to consider closely the disclosures in our Form 10-K which may be secured from us, or from the SEC's website at http://www.sec.gov/edgar.shtml.
News Today
MONTREAL, Mar 8, 2011 -- Shamika2Gold, Inc. (OTCBB:SHMX) ("Shamika" or the "Company") (www.Shamika2Gold.com) announced today that it has acquired 85% of MIG International Mining Group, a Mauritius company, which holds a concession of a gold and ruby exploration license in Cambodia. Shamika acquired the capital stock of MIG in exchange for 57,000,000 shares of Shamika common stock and shares of Series B Performing Preferred Stock entitling the holder to 45% of the net operating profit from the mining project. The shares issued by Shamika will be held in escrow until MIG obtains all necessary production licenses and has commenced commercial production for two months.
The area covered in the license is comprised of approximately 158 square miles in the Samlaut district of Cambodia. A Phase 1 & 2 Survey Report on the area was prepared by Terra Insight Services, Inc., a subsidiary of Terra Energy & Resource Technologies, Inc. and suggests potential for 1.5 million ounces of gold and 9,000 kilograms of rubies.
"This is a historic acquisition for Shamika," stated Robert Vivian, President and Chief Executive Officer. "Shamika's strategy is to discover, develop, and produce gold from potential high-value projects in overlooked and emerging countries. We seek out management teams that are known for their local expertise and the ability to work internationally with a high-growth company like Shamika. The acquisition of MIG international Mining Group brings to Shamika both an exceptional property package, and an outstanding team."
"This acquisition will allow the Company to rapidly advance our Asian portfolio. We expect it to contribute to both revenue and earnings in the next nine to twelve months," added Mr. Vivian.
Shamika has developed an aggressive plan to bring the MIG projects into production during calendar year 2011, and will alert shareholders to further developments in the next months.
Visit: www.shamrockstocks.com
About Shamrockstocks.com
Shamrockstocks.com is a website that profiles stocks of interest. We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by Shamrockstocks. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed.
For additional information, please contact info@shamrockstocks.com, www.shamrockstocks.com or www.twitter.com/shamrockstocks.
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com)).
No comments:
Post a Comment